Current status of clozapine in the United States

por Kelly, Deanna L., Wehring, Heidi J., Vyas, Gopal
Publicado 2012

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection

por Wehring, Heidi J., Thedford, Sheryl, Koola, Maju, Kelly, Deanna L.
Publicado 2011

Analysis of Pharmacist-Provided Medication Therapy Management(MTM) Services in Community Pharmacies Over 7 Years

por Barnett, Mitchel, Frank, Jessica, Wehring, Heidi, Newland, Brand, VonMuenster, Shannon, Kumbera, Patty, Halterman, Tom, Perry, Paul J.
Publicado 2009

O9.1. SATISFACTION WITH USING A NOVEL FINGERSTICK FOR ABSOLUTE NEUTROPHIL COUNT (ANC) AT THE POINT OF TREATMENT IN PATIENTS TREATED WITH CLOZAPINE

por Kelly, Deanna, Glassman, Matthew, Mackowick, Marie, Park, Jae, Navarro-De La Vega, Myriam, Wehring, Heidi, Vyas, Gopal, Richardson, Charles
Publicado 2020

Peripheral Cortisol and Inflammatory Response to a Psychosocial Stressor in People with Schizophrenia

por Glassman, Matthew, Wehring, Heidi J, Pocivavsek, Ana, Sullivan, Kelli M, Rowland, Laura M, McMahon, Robert P, Chiappelli, Joshua, Liu, Fang, Kelly, Deanna L
Publicado 2018

The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report

por Lee, Mary R., Wehring, Heidi J., McMahon, Robert P., Liu, Fang, Linthicum, Jared, Buchanan, Robert W., Strauss, Gregory P., Rubin, Leah H., Kelly, Deanna L.
Publicado 2019

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management...

por Kelly, Deanna L, Wehring, Heidi J, Earl, Amber K, Sullivan, Kelli M, Dickerson, Faith B, Feldman, Stephanie, McMahon, Robert P, Buchanan, Robert W, Warfel, Dale, Keller, William R, Fischer, Bernard A, Shim, Joo-Cheol
Publicado 2013